Want to join the conversation?
$BMY's 1Q16 revenue grew 9% versus 1Q15 due to higher Opdivo, Eliquis and Daklinza product sales. US and Europe revenue rose in the quarter, mainly due to higher demand for Opdivo and Eliquis. Decrease in Rest of the World revenue was driven by lower demand due to increased competition for the Hepatitis C Franchise in Japan.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!